Adaptive Control of Innate Immunity

Por Shanker, Anil
Publicado em 2010

NK cells: immune cross-talk and therapeutic implications

Por Malhotra, Anshu, Shanker, Anil
Publicado em 2011

Notching tumor: Signaling through Notch receptors improves antitumor T cell immunity

Por Uzhachenko, Roman, Shanker, Anil
Publicado no Oncoimmunology (2016)

Development of Proteasome Inhibitors as Therapeutic Drugs

Por Pellom, Samuel Troy, Shanker, Anil
Publicado em 2012

Cooperativity of adaptive and innate immunity: implications for cancer therapy

Por Shanker, Anil, Marincola, Francesco M.
Publicado em 2011

Modulation of anti-tumor lymphocyte function by neurotransmitter glutamate

Por Hodo, Thomas, Thounaojam, Menaka, Shanker, Anil
Publicado no J Immunother Cancer (2014)

From immunogenetic polymorphism to functional antitumor lymphocyte mitochondrial dynamics

Por Uzhachenko, Roman, Thounaojam, Menaka, Shanker, Anil
Publicado no J Immunother Cancer (2015)

Computational properties of mitochondria in T cell activation and fate

Por Uzhachenko, Roman, Shanker, Anil, Dupont, Geneviève
Publicado no Open Biol (2016)

Cooperative action of CD8 T lymphocytes and natural killer cells controls tumour growth under conditions of restricted T-cell receptor diversity

Por Shanker, Anil, Buferne, Michel, Schmitt-Verhulst, Anne-Marie
Publicado em 2010

Upregulation of neuroreceptors on CD4+ and CD8+ T cells promotes their anti-tumor function

Por de Aquino, Maria Teresa, Hodo, Thomas, Shanker, Anil
Publicado no J Immunother Cancer (2015)

Tributyltin Exposure Alters Cytokine Levels in Mouse Serum

Por Lawrence, Shanieek, Pellom, Samuel T., Shanker, Anil, Whalen, Margaret M.
Publicado no J Immunotoxicol (2016)

Bortezomib enhances anti-tumor T cell immunity by remodeling Notch system

Por Thounaojam, Menaka, Dudimah, Duafalia, Carbone, David, Dikov, Mikhail, Shanker, Anil
Publicado no J Immunother Cancer (2014)

Cross-talk between CD8+ T cells and natural killers: the role of mitochondrial Aa2+ transport

Por Uzhachenko, Roman, Goodwin, Shawn, Thounaojam, Menaka, Hofmeister, William, Shanker, Anil
Publicado no J Immunother Cancer (2014)

Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity

Por Uzhachenko, Roman, Shanker, Anil, Yarbrough, Wendell G., Ivanova, Alla V.
Publicado no Oncotarget (2015)

Butyrate Regulates the Expression of Inflammatory and Chemotactic Cytokines In Human Acute Leukemic Cells During Apoptosis

Por Pulliam, Stephanie R., Pellom, Samuel T., Shanker, Anil, Adunyah, Samuel E.
Publicado no Cytokine (2016)

Common Gamma Chain Cytokines in Combinatorial Immune Strategies against Cancer

Por Pulliam, Stephanie R., Uzhachenko, Roman V., Adunyah, Samuel E., Shanker, Anil
Publicado no Immunol Lett (2015)

Challenges and future perspectives of T cell immunotherapy in cancer

Por de Aquino, Maria Teresa P, Malhotra, Anshu, Mishra, Manoj K, Shanker, Anil
Publicado no Immunol Lett (2015)

Bortezomib sensitizes human renal cell carcinomas to TRAIL apoptosis via increased activation of caspase-8 in the death-inducing signaling complex

Por Brooks, Alan D., Jacobsen, Kristen M., Li, Wenqing, Shanker, Anil, Sayers, Thomas J.
Publicado em 2010

Modulatory effects of bortezomib on host immune cell functions

Por Pellom, Samuel Troy, Dudimah, Duafalia Fred, Thounaojam, Menaka Chanu, Sayers, Thomas Joseph, Shanker, Anil
Publicado no Immunotherapy (2015)

Innate-Adaptive Immune Crosstalk

Por Shanker, Anil, Thounaojam, Menaka C., Mishra, Manoj K., Dikov, Mikhail M., Uzhachenko, Roman V.
Publicado no J Immunol Res (2015)